We also acknowledge the lack of data on individuals with more recently discovered or suspected TBD genes (eg, DCLRE1B, RPA1, MDM4, NPM1, TYMS, POLA1)2 and likely over reporting of individuals with MDS, given MDS diagnostic challenges and inability to conduct central pathology review. This evidence concerns the gene POLA1 and myelodysplastic syndrome.